Search Results - "Reesink, H.W"

Human Liver NK Cells Are Phenotypically Different from Peripheral Blood Nk Cells by Stelma, F, de Niet, A, Sinnige, M.J, van Leeuwen, E.M.M, Kootstra, N.A, Reesink, H.W

Get full text

Plasma miR-122 levels in chronic hepatitis C patients achieving sustained virological response following DAA treatment with and without previous anti-miR-122 (RG-101) dosing by van der Ree, M.H, Stelma, F, Willemse, S.B, van der Valk, M, de Vree, J.M.L, Kootstra, N.A, Reesink, H.W

Get full text

P0660 : A specific KIR/HLA-C genotype is associated with immune activity and response to peginterferon and adefovir in HBeAg-positive chronic hepatitis B patients by Stelma, F, Jansen, L, Sinnige, M.J, van Leeuwen, E.M, Kootstra, N.A, Reesink, H.W

Get full text

Human Liver CD8+ T Cells Have a Tissue Resident Phenotype which is Altered in the Presence of Chronic Viral Infection by Stelma, F, de Niet, A, Sinnige, M.J, van Dort, K.A, van Leeuwen, E.M.M, Kootstra, N.A, Reesink, H.W

Get full text

No change in hepatitis C virus-specific T cell functionality after successful DAA treatment in chronic hepatitis C patients by Stelma, F, van der Ree, M.H, Sinnige, M.J, Brown, A, Swadling, L, Willemse, S.B, van der Valk, M, de Vree, J.M, Klenerman, P, Barnes, E, Kootstra, N.A, Reesink, H.W

Get full text

509 SERUM IP10 LEVELS AT BASELINE AND DURING THERAPY DO NOT PREDICT SVR IN CHRONIC HEPATITIS C PATIENTS TREATED WITH HIGH INDUCTION DOSE INTERFERON by Willemse, S.B, Gelderblom, H.C, Molenkamp, R, Reesink, H.W, Schinkel, J

Get full text

P182 VIRAL PARTICLES CONTAINING HBVRNA ARE PRESENT IN PLASMA BEFORE AND DURING NUCLEOS(T)IDE ANALOGUE TREATMENT OF CHRONIC HEPATITIS B PATIENTS by Jansen, L, van Dort, K.A, Kootstra, N.A, Reesink, H.W, Zaaijer, H.L

Get full text

P720 HEALTH-RELATED QUALITY OF LIFE (HRQL) AND PATIENT-REPORTED OUTCOMES (PROS) ASSESSMENT IN CHRONIC HEPATITIS C (CH-C) TREATED WITH SOFOSBUVIR (SOF) AND RIBAVIRIN (RBV): THE VALENCE STUDY by Younossi, Z.M, Stepanova, M, Zeuzem, S, Reesink, H.W, Weiland, O, Nader, F, Hunt, S.L

Get full text

P0659 : Cytokine responses in chronic hepatitis B patients dosed with the nucleic-acid polymer REP2139-Ca by Stelma, F, Vaillant, A, Jansen, L, Sinnige, M.J, van Leeuwen, E.M, Kootstra, N.A, Bazinet, M, Al-Mahtab, M, Reesink, H.W

Get full text

O114 : Serum HBV-RNA levels decline significantly in chronic hepatitis B patients dosed with the nucleic-acid polymer REP2139-CA by Jansen, L, Vaillant, A, Stelma, F, Kootstra, N.A, Bazinet, M, Al-Mahtab, M, Reesink, H.W

Get full text

P0490 : NK cell dynamics in chronic hepatitis B patients are associated with HBsAg clearance after combination treatment with peginterferon ALFA-2A and adefovir by Stelma, F, de Niet, A, Jansen, L, Takkenberg, R.B, Janssen, H.L, Sinnige, M.J, Kootstra, N.A, van Leeuwen, E.M, Reesink, H.W

Get full text

P0670 : Plasma microrna levels are associated with therapy response in chronic hepatitis B patients treated with peginterferon and adefovir by Van Der Ree, M, Jansen, L, van Dort, K, Takkenberg, B, Kootstra, N.A, Reesink, H.W

Get full text

A Single Dose of Anti-MIR122 Oligonucleotide RG-101 Results in a less Activated Phenotype of NK Cells in Patients with Chronic Hepatitis C by Stelma, F, van der Ree, M.H, Sinnige, M.J, Marleen de Vree, J, Willemse, S.B, van der Valk, M, Neben, S, Grint, P, Kootstra, N.A, Reesink, H.W

Get full text

Sequence Analysis for Resistance Monitoring following a Single Dose of RG-101, an Anti-MIR Targeting Microrna-122, in Chronic Hepatitis C Patients by van der Ree, M.H, Stelma, F, de Vree, J.M.L, Willemse, S.B, van der Valk, M, van Nuenen, Ad.C, Patick, A, Grint, P, Neben, S, Pavlicek, A, van der Veer, E, Kootstra, N.A, Reesink, H.W

Get full text

P181 GENE SET ENRICHMENT ANALYSIS IN BASELINE LIVER BIOPSIES OF CHRONIC HEPATITIS B PATIENTS TREATED WITH PEGINTERFERON-ALFA AND ADEFOVIR by Jansen, L, de Niet, A, Makowska, Z, Dill, M.T, van Dort, K.A, Takkenberg, R.B, Heim, M.H, Kootstra, N.A, Reesink, H.W

Get full text

P685 BASELINE LIVER BIOPSY CHARACTERISTICS ASSOCIATED WITH RESPONSE IN CHRONIC HEPATITIS B PATIENTS TREATED WITH PEGINTERFERON-ALFA AND ADEFOVIR by Jansen, L, Takkenberg, R.B, de Niet, A, Terpstra, V, Kootstra, N.A, Janssen, H.L.A, Reesink, H.W

Get full text

LP29 : A randomised prospective open-label trial comparing peginterferon + adefovir and peginterferon + tenofovir versus no treatment in hbeag negative chronic hepatitis b patients with low viral load: analysis of week 48 results by de Niet, A, Jansen, L, Stelma, F, Willemse, S.B, Kuiken, S.D, Weijer, S, van Nieuwkerk, K.M, Zaaijer, H.L, Molenkamp, R, Takkenberg, R.B, Koot, M, Verheij, J, Beuers, U, Reesink, H.W

Get full text

LO7 : A single subcutaneous dose of 2mg/kg or 4mg/kg of RG-101, a GalNAc-conjugated oligonucleotide with antagonist activity against MIR-122, results in significant viral load reductions in chronic hepatitis C patients by Van Der Ree, M, de Vree, M.L, Stelma, F, Willemse, S, van der Valk, M, Rietdijk, S, Molenkamp, R, Schinkel, J, Hadi, S, Harbers, M, van Vliet, A, Udo de Haes, J, Grint, P, Neben, S, Gibson, N, Reesink, H.W

Get full text

411 A NEW HBsAg/ANTI-HBs IMMUNE COMPLEX ASSAY PREDICTS HBeAG LOSS IN CHRONIC HEPATITIS B PATIENTS by de Niet, A, Zaaijer, H.L, Klause, U, Jansen, L, Takkenberg, B, Janssen, H.L.A, Chu, T, Petric, R, Reesink, H.W

Get full text

898 TREATMENT WITH TELAPREVIR/PEG-IFN/RBV AFTER 14-DAY TELAPREVIR EXPOSURE IN PHASE I STUDIES: RESULTS FROM THE PHASE IIIB C219 ROLLOVER STUDY by Sarrazin, C, Reesink, H.W, Zeuzem, S, Dierynck, I, Luo, D, Witek, J, Picchio, G, De Meyer, S

Get full text